GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_231/2024

Sibio Technology Limited v Abbott Diabetes Care Inc.

Datum
2025-07-21
Kammer
Paris (FR) Central Division - Seat
Verfahrensart
Revocation Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_231-2024-02e52a197ff0
Aktenzeichen
RegisterzeichenUPC_CFI_231/2024
EntscheidungsreferenzORD_69322/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 29

Central Division Paris Seat DECISION of the Court of First Instance of the Unified Patent Court Central division - Paris seat issued on 21 July 2025 in the revocation action No. ACT_27463/2024 UPC_CFI_231/2024 HEADNOTES: 1. Lack of novelty and lack of an inventive step are separate grounds for revoking a patent and cannot be absorbed when asserted against the same prior art document. Simply indicating in general terms that a prior art document will be used to challenge the patent's novelty and/or inventive step, providing a detailed analysis of the document only with respect to inventive step, is insufficient to establish that the document is being used to challenge the patent's novelty. 2. Although the dependent claims are subordinated to the independent claims, the grounds for their revo ...